{
    "clinical_study": {
        "@rank": "88937", 
        "acronym": "TEMPEST", 
        "arm_group": [
            {
                "arm_group_label": "PredA q1h WA + Kelac qid", 
                "arm_group_type": "Active Comparator", 
                "description": "PredA q1h WA + Kelac qid"
            }, 
            {
                "arm_group_label": "PredA qid + Kelac qid", 
                "arm_group_type": "Active Comparator", 
                "description": "PredA qid + Kelac qid"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the change in visual acuity of patients with post\n      surgical cystoid macular edema who will be treated with two different regimens."
        }, 
        "brief_title": "Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST)", 
        "condition": "Post-surgical Cystoid Macular Edema (PSCME)", 
        "condition_browse": {
            "mesh_term": [
                "Edema", 
                "Macular Edema"
            ]
        }, 
        "detailed_description": {
            "textblock": "Compare the mean change in BCVA over 12 weeks of Prednisolone Acetate 1% q1h (every hour) WA\n      (While Awake)+ Ketorolac 0.5% qid ( four times a day) versus Prednisolone Acetate qid +\n      Ketorolac qid for post surgical cystoid macular edema."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age more than or equal to 18 years\n\n          -  Diagnosis of PSCME in study eye confirmed by FA showing leakage from retinal vessels\n             resulting in pooling of dye in the fovea and Spectralis SD-OCT showing intraretinal\n             fluid in or around the fovea.\n\n          -  BCVA score in the study eye of 20/30 to 20/400 inclusive (Snellen equivalents using\n             the ETDRS protocol at a distance of 4 meters).\n\n          -  In the opinion of the investigator, decreased vision in the study eye is due to\n             foveal thickening from PSCME and not to any other reason.\n\n        Exclusion Criteria:\n\n          -  Any patient who has other retinal diseases known to cause macular edema (choroidal\n             neovascularization, vein occlusion, diabetic macular edema in the study eye).\n             Patients with nonexudative Age Related Macular Degeneration (ARMD) or\n             non-proliferative diabetic retinopathy without macular edema can be included in the\n             study.\n\n          -  Other reason for decreased visual acuity (such as amblyopia, foveal atrophy, optic\n             atrophy).\n\n          -  Pre-existing diagnosis of glaucoma in the study eye\n\n          -  Inability to comply with study or follow up procedures\n\n          -  Pregnancy (Women of child bearing age will be asked to take a urine pregnancy test\n             prior to enrolling in the study)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "46", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01769352", 
            "org_study_id": "NA_00074523"
        }, 
        "intervention": {
            "arm_group_label": [
                "PredA q1h WA + Kelac qid", 
                "PredA qid + Kelac qid"
            ], 
            "intervention_name": "PredA  + Kelac", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 12, 2014", 
        "location": {
            "contact": {
                "last_name": "Gulnar Hafiz, MD MPH"
            }, 
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21287"
                }, 
                "name": "Wilmer Eye Institute"
            }, 
            "investigator": [
                {
                    "last_name": "Peter A Campochiaro, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Claudia M Krispel, MD, PHD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Raafay Sophie, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST)", 
        "overall_contact": {
            "email": "ghafiz1@jhmi.edu", 
            "last_name": "Gulnar Hafiz, MD, MPH"
        }, 
        "overall_official": {
            "affiliation": "Johns Hopkins University", 
            "last_name": "Peter A Campochiaro, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Mean change from baseline in BCVA", 
            "safety_issue": "No", 
            "time_frame": "12 Weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01769352"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Johns Hopkins University", 
            "investigator_full_name": "Peter A Campochiaro, MD", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Johns Hopkins University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Johns Hopkins University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}